Citation Impact

Citing Papers

A new dysferlin gene mutation in two Japanese families with limb-girdle muscular dystrophy 2B and Miyoshi myopathy
2001
Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis
2008
Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome
2015 StandoutNobel
A cell-free platform for the prenylation of natural products and application to cannabinoid production
2019 StandoutNobel
CONSORT 2010 statement: extension to randomised pilot and feasibility trials
2016 Standout
Prospective Association Between C-Reactive Protein and Fatigue in the Coronary Artery Risk Development in Young Adults Study
2009
Myelin damage and repair in pathologic CNS: challenges and prospects
2015
Parkinson disease
2017 Standout
Supportive Care for Patients With Guillain-Barré Syndrome
2005
NeuPSIG guidelines on neuropathic pain assessment
2010 Standout
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis
2008 Standout
The Role of Short-Chain Fatty Acids in Health and Disease
2014 Standout
Self-report fatigue questionnaires in multiple sclerosis, Parkinson’s disease and stroke: a systematic review of measurement properties
2011
Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms
2019 Standout
Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome
2008
Recognition, diagnosis, and treatment of primary focal hyperhidrosis
2004 Standout
Cochrane reviews of educational and self-management interventions to guide nursing practice: A review
2008 Standout
Are the Dorsal and Ventral Hippocampus Functionally Distinct Structures?
2010 Standout
A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome
2012
Guillain-Barré syndrome
2016 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Physiology and immunology of the cholinergic antiinflammatory pathway
2007 Standout
Parkinson's disease: clinical features and diagnosis
2008 Standout
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
Peripheral neuropathy
2004
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
The muscular dystrophies
2002 Standout
Guillain–Barré Syndrome
2012 Standout
Biological correlates of post-stroke fatigue: a systematic review
2011
Cognitive impairment in multiple sclerosis
2008 Standout
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies
2011 Standout
Where Is the Semantic System? A Critical Review and Meta-Analysis of 120 Functional Neuroimaging Studies
2009 Standout
Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review) [RETIRED]
2008
Sleep Duration and All-Cause Mortality: A Systematic Review and Meta-Analysis of Prospective Studies
2010 Standout
Association of C-reactive protein and interleukin-6 with new-onset fatigue in the Whitehall II prospective cohort study
2012
Irritable bowel syndrome
2016 Standout
Incidental Findings on Brain MRI in the General Population
2007 Standout
COSMIN guideline for systematic reviews of patient-reported outcome measures
2018 Standout
Depression in multiple sclerosis: Review and theoretical proposal
2008
The role of the posterior cingulate cortex in cognition and disease
2013 Standout
Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease
2009
Rhythmic cued motor imagery and walking in people with multiple sclerosis: a randomised controlled feasibility study
2015
Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes
2005
Resting-State Functional Connectivity Reflects Structural Connectivity in the Default Mode Network
2008 Standout
Vascular cognitive impairment
2003 Standout
Treadmill training for individuals with multiple sclerosis: a pilot randomised trial
2006
Post-Stroke Fatigue: Epidemiology, Clinical Characteristics and Treatment
2014 Standout
Doppler Haemodynamics of Cerebral Venous Return
2008
Minimum data elements for research reports on CFS
2012 StandoutNobel
How do you feel — now? The anterior insula and human awareness
2008 Standout
Stress System – Organization, Physiology and Immunoregulation
2006
The Genetics and Epigenetics of Fatigue
2010
Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study
2016
Non-motor features of Parkinson disease
2017 Standout
Progressive resistance exercise for people with multiple sclerosis
2006
Effects of mindfulness on psychological health: A review of empirical studies
2011 Standout
Cancer-related fatigue—mechanisms, risk factors, and treatments
2014 Standout
Fatigue in Parkinson's disease: A review
2006
NAFLD: A multisystem disease
2015 Standout
Mapping the Structural Core of Human Cerebral Cortex
2008 Standout
Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 1: Where have we been and what have we learned?
2016
The Brain's Default Network
2008 Standout
Guillain-Barré syndrome
2005 Standout
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
2005 Standout
Differential release of mast cell mediators and the pathogenesis of inflammation
2007
Complex brain networks: graph theoretical analysis of structural and functional systems
2009 Standout
Fatigue, mood and quality of life improve in MS patients after progressive resistance training
2010
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Is cardiac function impaired in premotor Parkinson's disease? A retrospective cohort study
2013
Autonomic dysfunction in the ICU patient
2001
Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
2007
Overview of pharmacological activities ofAndrographis paniculataand its major compound andrographolide
2018 Standout
Information provision for people with multiple sclerosis
2014
Neural connections of the posteromedial cortex in the macaque
2006
Global Epidemiology of Campylobacter Infection
2015 Standout
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
MRI white matter hyperintensities
1999
PD-1 deficiency reveals various tissue-specific autoimmunity by H-2band dose-dependent requirement of H-2g7for diabetes in NOD mice
2008 StandoutNobel
Defining and analyzing geoepidemiology and human autoimmunity
2010
MS quality of life, depression, and fatigue improve after mindfulness training
2010
Resistance training improves strength and functional capacity in persons with multiple sclerosis
2004
Effect of exercise training on quality of life in multiple sclerosis: a meta-analysis
2007 Standout
Sativex ® as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial
2018
Quantity and Quality of Sleep and Incidence of Type 2 Diabetes
2009 Standout
Guillain–Barré syndrome, CIDP and other chronic immune‐mediated neuropathies
1998
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis
2015
Brain Derived Neurotrophic Factor is Decreased in Chronic Fatigue Syndrome and Multiple Sclerosis
2013
Incidence, Manifestations, and Predictors of Worsening White Matter on Serial Cranial Magnetic Resonance Imaging in the Elderly
2004

Works of Peter Flachenecker being referenced

Linguistic and psychometric validation of the MSSS-88 questionnaire for patients with multiple sclerosis and spasticity in Germany
2014
Quantitative assessment of cardiovascular autonomic function in Guillain‐Barré syndrome
1997
„Fatigue“ bei Multipler Sklerose
2005
Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice
2014
Fatigue and Regulation of the Hypothalamo-Pituitary-Adrenal Axis in Multiple Sclerosis
2005
Clinical outcome of sural nerve biopsy: a retrospective study
1999
Detection of serious bradyarrhythmias in Guillain-Barré syndrome: Sensitivity and specificity of the 24-hour heart rate power spectrum
2000
National MS registries
2008
Determination of ventricular diameters in multiple sclerosis patients with transcranial sonography (TCS)
2004
Twenty-four-hour heart rate power spectrum for evaluation of autonomic dysfunction in Guillain–Barré syndrome
1999
Epidemiology of neuroimmunological diseases
2006
Selective degeneration of sudomotor fibers in Ross syndrome and successful treatment of compensatory hyperhidrosis with botulinum toxin
1998
Implementation of a patient education program on multiple sclerosis relapse management
2011
Cardiovascular autonomic dysfunction in multiple sclerosis: correlation with orthostatic intolerance
1999
Autonomic dysfunction in ALS: A preliminary study on the effects of intrathecal BDNF
2005
Distal muscular dystrophy of Miyoshi type
1996
Power spectrum analysis of heart rate variability in Guillain-Barre syndrome. A longitudinal study
1997
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity
2014
Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I)
2013
The role of stress-response systems for the pathogenesis and progression of MS
2005
Cytokine mRNA expression in patients with multiple sclerosis and fatigue
2004
Spasticity in patients with multiple sclerosis - clinical characteristics, treatment and quality of life
2013
Fatigue in MS is related to sympathetic vasomotor dysfunction
2003
Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters
2002
A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost–effectiveness in Germany
2013
[Course of illness and prognosis of multiple sclerosis. 1: The natural illness course].
1996
Rankless by CCL
2026